Navigation Links
Valeant Pharmaceuticals Files Presentation for Cephalon Stockholders
Date:4/11/2011

ing untested biotech products departs dramatically from Cephalon's historical focus of marketing products other companies have primarily developed and taken through the regulatory process.
  • Cephalon is not a high-growth biotechnology company.  Provigil, which accounted for approximately 41% of its net sales in fiscal year 2010, will face generic competition next year.  Based on IBES consensus equity research estimates, from 2011-2013, Cephalon's revenues and EPS are expected to fall by 20% and 42%, respectively.
  • Cephalon's share price performance prior to Valeant's offer reflected its declining fundamental value. Repeated pipeline failures and an inability to fill the impending loss of Provigil have negatively impacted Cephalon's valuation.  In fact, Cephalon's 52-week high was following rumors of a sale process and dropped off sharply after Cephalon was unable to attain approval for Nuvigil for the treatment of jet lag.  Concern over Cephalon's business model was demonstrated by 68% of Wall Street analysts having ratings equivalent to "sell" or "hold" prior to Valeant's offer.
  • Valeant's offer represents a full and fair premium. Valeant's $73 per share all cash offer represents a 29% premium to Cephalon's 30-day trading average at announcement.  The median premium to 30-day trading averages in all U.S. acquisitions since 2006 was 25%, and 60% of those acquisitions were completed at a premium of less than 30% to 30-day trading averages.  In addition, Valeant's offer already accounts for the substantial value leakage due to change of control costs for Cephalon's convertible debt and call spread.

  • Timing is critical to Valeant.  Wall Street analysts project Cephalon's earnings to decline by more than 40% after Provigil loses patent protection in 2012.  Cephalon's value to Valeant erodes each day Valeant is delayed in implementing its business strategy as Provi
    '/>"/>

    SOURCE Valeant Pharmaceuticals International, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6

    Related medicine technology :

    1. Valeant Pharmaceuticals Files Preliminary Consent Solicitation Statement With the SEC
    2. Promius Pharma and Valeant Form Collaboration to Market Cloderm® Cream in the United States
    3. Valeant Pharmaceuticals Proposes to Acquire Cephalon, Inc. for $73 Per Share in Cash
    4. GSK and Valeant Receive European Authorisation for Trobalt (retigabine)
    5. Valeant Pharmaceuticals Extends Contract with J. Michael Pearson as CEO and Appoints Him as Chairman of the Board
    6. Valeant Pharmaceuticals Completes Acquisition of PharmaSwiss S.A.
    7. Valeant Announces Pricing of Senior Notes
    8. Valeant Launches Senior Notes Offering
    9. Valeant Pharmaceuticals to Present at RBC Capital Markets 2011 Healthcare Conference
    10. Valeant Pharmaceuticals to Announce 2010 Fourth Quarter and Full Year Results on February 24, 2011
    11. Valeant Pharmaceuticals Announces License Of ACZONE® (dapsone) Gel 5% In Canada
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:1/23/2015)... 23, 2015  Lixte Biotechnology Holdings, Inc. (OTCQB: LIXT), announced that ... of Lixte,s lead compound, LB‑100, is being conducted, has been ... S. Kovach , M.D., the founder and President of Lixte, ... at a single site. Accrual of patients, however, was slower ...
    (Date:1/23/2015)... TOWN, South Africa , Jan. 23, 2015   ... distributor of personal protective equipment for all forms of ... the flagship Leatt-Brace® neck brace, announced today that the ... racing federation, now requires all riders to wear a ...
    (Date:1/23/2015)... plc (NYSE: MNK ) announced today that ... program. The open-ended authorization permits the company to repurchase ... "Funding additional initiatives and seeking attractive ... to pursue a range of focused growth strategies," said ...
    Breaking Medicine Technology:Lixte Biotechnology Holdings Announces Expansion Of Clinical Sites For Its Phase I Trial Of Its Lead Anti-Cancer Compound, LB-100 2Lixte Biotechnology Holdings Announces Expansion Of Clinical Sites For Its Phase I Trial Of Its Lead Anti-Cancer Compound, LB-100 3Leatt Announces Neck Braces Now Required For Motocross/Minicross Racing In Italy 2Leatt Announces Neck Braces Now Required For Motocross/Minicross Racing In Italy 3Mallinckrodt plc Announces Share Repurchase Program 2Mallinckrodt plc Announces Share Repurchase Program 3Mallinckrodt plc Announces Share Repurchase Program 4
    (Date:1/22/2015)... 2015 LunaDress, with its top dressmaking technologies, ... Now, the business is showing its latest designs of wedding ... According to the company’s CEO, all the fresh new products ... big discounts, up to 80% off. All the clothes from ...
    (Date:1/22/2015)... Padre Murphy's and Owner Tom Boyle in Glendale, AZ ... Alliance (PPHA). The PPHA's passion for others' well-being and ... greats, treated for obstructive sleep apnea (OSA) has propelled them ... in the valley. The most recent plans for an event ...
    (Date:1/22/2015)... 2015 Blue Cross and Blue Shield of ... what it means to “Live Fearless.” , The ... share their stories about how they or someone they know ... by living in the moment. By telling these types of ...
    (Date:1/22/2015)... A new white paper by The Beryl ... the long-term care environment as well as provides recommendations ... paper, “The Power of Person-Centeredness in Long-Term Care: A ... the patient, resident and family experience in long-term care ...
    (Date:1/22/2015)... Carinsurancesavings.biz has released a new blog post presenting the ... , Purchasing an accidental death and dismemberment rider for ... of rider provides benefits if the insured dies in an ... form of life insurance. , AD&D is not expensive ...
    Breaking Medicine News(10 mins):Health News:LunaDress Shows The Latest Styles Of Wedding Dresses In 2015 2Health News:Padre Murphy's Holds NFL Retired Players Association Party Star Studded Event With Bud Light and Pro Player Health Alliance Sponsoring 2Health News:Padre Murphy's Holds NFL Retired Players Association Party Star Studded Event With Bud Light and Pro Player Health Alliance Sponsoring 3Health News:Blue Cross and Blue Shield of Minnesota to Showcase “Faces of Fearless” 2Health News:The Power of Person-Centeredness in Long-Term Care Explored by The Beryl Institute 2Health News:The Power of Person-Centeredness in Long-Term Care Explored by The Beryl Institute 3Health News:Accidental Death and Dismemberment Insurance Can Be Purchased at Low Prices Online 2
    ... only helps with material that was learned well, study suggests ... midday nap can help boost your memory and remember facts, ... place, a new study suggests. , This type of memory ... and knowledge, in contrast to "procedural memory," which applies to ...
    ... Perrigo Company,(Nasdaq: PRGO ; TASE) today announced ... of $150 million of the Company,s common stock,through ... program. Any,remaining balance of the previously authorized program ... programs since November 2000,Perrigo has repurchased 11.4 million ...
    ... by changing the motion and structure of a proton channel ... a recently published research paper by two Iowa State University ... in Chemistry, and Sarah Cady, a graduate student in chemistry, ... influenza A. Thats the type of flu bug that most ...
    ... WHAT: Prevent Blindness America and VSP(R) Vision Care will sponsor a ... Health -- A Briefing on Pre-Diabetes ... presented to the congressional staff., WHY: 21 million ... are living with this disease. It,s even more startling to think ...
    ... LTC Sector Required for Accurate Evaluation of,Seniors, Ongoing Funding ... January,31 New York Times news article reporting the Bush ... to help care for the growing,number of seniors who ... Nursing Home Care said it will work in 2008 ...
    ... Propofol coverage isn,t reinstated, NEW YORK, Feb. 1 ... refusal to cover Propofol under all circumstances,is getting louder. ... a call to file a consumer fraud lawsuit,against Aetna ... New York State issue has now become a national,campaign., ...
    Cached Medicine News:Health News:A Daytime Nap Can Boost Memory 2Health News:Iowa State chemists track how drug changes, blocks flu virus 2Health News:In Unfolding Budget Debate, Alliance to Spotlight Flawed MedPAC Policy Guidance, Failure to Evaluate Medicaid Margins in Recommending Medicare Funding Levels 2Health News:National Health Care Alliance Gains New Members Against Aetna's New Anesthesia Policy 2Health News:National Health Care Alliance Gains New Members Against Aetna's New Anesthesia Policy 3
    Straight shafts with 15 mm long jaws. Serrated handle with polished finish. Smooth jaws....
    Straight shafts with 3 mm platform. Wide serrated handle with polished finish....
    Curved shafts with fine 1 x 2 teeth. Flat handle with holes and polished finish....
    Atraumatic forceps with fine 1 mm ring tips provide firm grasp without the damage caused by tooth or serrated forceps. Wide serrated handle. Polished finish....
    Medicine Products: